Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
9 Meters Biopharma (NMTRQ)
OTHER OTC:NMTRQ
Holding NMTRQ?
Track your performance easily
NMTRQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.02
Volume1.80K
Average Volume (3M)N/A
Market Cap
$14.00
Enterprise Value-$2.42M
Total Cash (Recent Filing)$7.58M
Total Debt (Recent Filing)$5.17M
Price to Earnings (P/E)―
Beta294.87
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,459,690
10 Day Avg. Volume2,099
30 Day Avg. VolumeN/A
Standard Deviation12.80
R-Squared0.04
Alpha0.95
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
9 Meters Biopharma News
Ownership Overview
―
Insiders
<0.01% Mutual Funds
11.67% Other Institutional Investors
88.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NMTRQ FAQ
What was 9 Meters Biopharma’s price range in the past 12 months?
Currently, no data Available
What is 9 Meters Biopharma’s market cap?
Currently, no data Available
When is 9 Meters Biopharma’s upcoming earnings report date?
9 Meters Biopharma’s upcoming earnings report date is May 14, 2024 which is 174 days ago.
How were 9 Meters Biopharma’s earnings last quarter?
Currently, no data Available
Is 9 Meters Biopharma overvalued?
According to Wall Street analysts 9 Meters Biopharma’s price is currently Overvalued.
Does 9 Meters Biopharma pay dividends?
9 Meters Biopharma does not currently pay dividends.
What is 9 Meters Biopharma’s EPS estimate?
9 Meters Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 9 Meters Biopharma have?
9 Meters Biopharma has 14,459,690 shares outstanding.
What happened to 9 Meters Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 9 Meters Biopharma?
Currently, no hedge funds are holding shares in NMTRQ
---
Company Description
9 Meters Biopharma
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
---
---